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microparticles, and the amounts of EMPs from plasma were increased. In ECs, along
with TF upregulation, miR-19b release and expression were increased stimulated by
TNF-a. Luciferase reporter assays demonstrated that miR-19b bind to TF mRNA.
Overexpression of miR-19b inhibited TF expression and procoagulant activity.
Conclusions: In UA patients, the increasement of miR-19b wrapped in EMPs for
endothelial dysfunction may partialy contributed to the circulating miR-19b elevation.
MiR-19b may play an anti-thrombotic role by inhibiting the expression of TF in ECs.
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Objectives: Endothelial progenitor cells (EPCs) contribute to angiogenesis and acidic
ﬁbroblast growth factor (FGF1) gene transfer enhances EPC function. The Forkhead box
O transcription factors (FOXOs) play an important role in the regulation of various
cellular processes and EPCs mainly express FOXO3a. Here, we aimed to determine
whether FGF1 promotes EPC function through Akt/FOXO3a signaling pathway.
Methods: EPCs were cultured from human peripheral blood and transduced with
adenoviral vectors expressing a non-phosphorylatable, constitutively active mutant of
FOXO3a (Ad-TM-FOXO3a) and the GFP transgene (Ad-GFP) used as control. The
Ad-GFP group treated with FGF1 showed the functional improvement including cell
survival, proliferation, migration and tube formation, whereas the above promoting
effects were reversed after adding Akt inhibitor.
Results: The Ad-TM-FOXO3a group showed the reduced functionality compared with
the control and failed to make the functional recovery after FGF1 treatment. Western
blotting revealed that FGF1 made EPC functional enhancement through upregulating
the phosphorylation of Akt and FOXO3a which could be suppressed by Akt inhibitor.
Conversely, FGF1 failed to rescue EPCs transduced with Ad-TM-FOXO3a from
dys-function because the mutant FOXO3a were not phosphorylated by Akt.
Conclusions: FGF1 promoting EPC function is mediated through Akt/FOXO3a
signaling pathway. The molecular mechanism of EPC functional improvement we
initially explored may provide new ideas for the future to enhance the EPC angiogenic
effect and optimize the EPC transplantation therapy.
GW25-e1550
Altered Serum MicroRNAs as Novel Diagnostic Biomarkers for Atypical
Coronary Artery Disease
Wang Jun1, Yong Zhong2, Cheng Wang3, Jiaqing Shao4, Jianbin Gong1
1Department of Cardiology, Jinling Hospital, School of Medicine, Nanjing
UniversityHospital of Nanjing Military Command, 2Department of Health-Care,
Jinling Hospital, School of Medicine, Nanjing UniversityHospital of Nanjing Military
Command, 3Department of Clinical Laboratory, Jinling Hospital, School of Medicine,
Nanjing UniversityHospital of Nanjing Military Command, 4Department of
Endocrinology, Jinling Hospital, School of Medicine, Nanjing UniversityHospital of
Nanjing Military Command
Objectives: Atypical coronary artery disease (ACAD) is characterized by atypical
angina pectoris or silent myocardial ischemia. However, conventional diagnostic
techniques are insufﬁcient to identify this subtype of coronary atherosclerotic pa-
thology, and speciﬁc and sensitive markers for diagnosing ACAD are still currently
lacking. The aim of the present study is to identify a novel serum miRNA expression
proﬁle of ACAD patients and evaluate its clinical diagnostic value.
Methods: We enrolled 122 patients who were diagnosed with ACAD and 44 age-
matched controls in this study. We examined the levels of a subset of serum miRNAs
in both ACAD and control samples. In addition, we sought to predict the potential
target genes of the altered miRNAs using bioinformatics methods.
Results: By using TaqMan low density array technology followed by conﬁrmation with
quantitative real-time PCR (qRT-PCR), we identiﬁed four miRNAs including miR-
487a, miR-502, miR-208 and miR-215 that were signiﬁcantly increased, and one
miRNA, miR-29b which was signiﬁcantly decreased in ACAD patients compared with
normal subjects (P< 0.05). The area under the ROC curve (AUC) for the ﬁve miRNAs
ranged from 0.670 to 0.876 (P< 0.05), and their panel (0.885) was signiﬁcantly higher
than that of hsTnI (0.627). In addition, target gene prediction showed that these ﬁve
altered miRNAs are involved in affecting various aspects of cardiac or vascular
remodeling, especially in the pathway involving inﬂammation and ﬁbrosis.
Conclusions: Our ﬁndings indicate that the ﬁve altered serum miRNAs could be
novel non-invasive biomarkers for ACAD and may also represent potential thera-
peutic targets for atherosclerosis and myocardial ischemia.
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Objectives: To explor the effects of trimetazidine on myocardial structure damaged
by pyran adriamycin and to clarify the protection and mechanism of trimetazidine on
damaged myocardial structure induced by pyran adriamycin.C64 JACC Vol 64/16/Suppl C j OctobMethods: 36 Wistar rats were randomly divided into control group, model group and
treatment group. Rats in model group and treatment group were injected pyran
doxorubicin 2.5mg/kg (concentration 2mg/ml) by the vena caudal once a week.
Control group were injected equivalent normal saline in a coordinative control for 6
weeks. Rats in treatment group were intragastric infuse trimetazidine 5.4mg/kg/d one
day before making the model. Control group, model group were injected equivalent
normal saline in a coordinative control for 8 weeks. At the end of the experiment,
index of heart mass of rats and myocardial enzymes of serum were measured. Systolic
and diastolic function were detected with echocardiography. The myocardium tissue
were detected by light microscope and electron microscope.
Results: Compared with model group, the level of myoglobin, troponin and alanine
transaminase (ALT) in treatment groupwere decreased (P<0.05). Index of heart mass in
treatment group is lower than that in model group and nearly the level of control group.
Compared with control group, EF and FS in model group decreased (P<0.01) and
LVIDD, LVIDS in creased (P<0.05). EF and FS in Group C is larger than that in Group
B (P<0.05), LVIDS, LVIDD in treatment group is lower than model group (P<0.05).
Under the lightmicroscope observation, inmodel groupmyocardial arranged disorderly,
severely damaged structure, multiple visibl emyocardial, myoﬁlament dissolved, frac-
ture, while in treatment group myocardial arranged in order, structure was nearly inte-
grated, partial dissolution, fracture. Under the electronmicroscope observation, inmodel
group myocardial muscle bundle dissolved fractured, disappeared, mitochondria
decreased, cytoplasmic matrix cavitation, while in treatment group, arrangement of
cardio myocytes sarcomeres in tow, local myoﬁlaments reduced slightly, surrounding
mitochondria were oval and arranged in parallel between the muscle bundles.
Conclusions: Trimetazidine can protect the damaged cardiomyocytes and improve the
cardiac function caused by pyran adriamycin, and its mechanism may be related to
decrease the injury of mitochondria and myocytes
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Objectives: Recent evidence indicates that platelet indices and white blood cell
(WBC) are associated with the prognosis of patients with acute aortic dissection (AD).
However, there have been no systematic investigations on the utility of baseline mean
platelet volume (MPV) to platelet count (PC) ratio (MPV/PC ratio) and WBC for
predicting the survival of acute AD. The present study was designed to examine
whether the MPV/PC ratio and WBC could predict mortality in acute AD
Methods: Baseline clinical details and hematologic parameters were obtained pro-
spectively in 272 acute AD patients consecutively admitted to a single medical center.
The levels of MPV, PC and WBC were determined after their initial admission and
evaluated, in concert with follow-up patient survival data, to determine if the MPV/PC
ratio and WBC could predict mortality. Between initial measurement and follow-up
(medium time: 570 (11-1222.5) days)
Results: Increased levels of plasma MPV/PC ratio (6.3513 (4.6439-8.8730) versus
5.3939 (4.068-6.7415), P<0.001) and WBC (11.90 (8.85-16.03) vs 9.91 (7.46-13.05),
P<0.001)were found indead patients comparedwith those survivedduring the follow-up.
Multivariable analysis showed that MPV/PC ratio (P¼0.014, OR¼1.179, 95% CI: 1.034
to 1.344) and WBC (P¼0.011, OR¼1.106, 95% CI: 1.024 to 1.195) was an independent
predictor for all-cause mortality during follow-up, respectively. The areas under receiver
operating characteristic (ROC) curves of MPV/PC ratio and WBC were 0.618 (95% CI:
0.542 to 0.694) and 0.625 (95% CI: 0.553 to 0.698) for predicting follow-up mortality,
with a sensitivity of 39.8%, speciﬁcity of 88.1%, cut-off valueof 7.55197102fL/ (109/L)
and a sensitivity of 52.7%, speciﬁcity of 68.9%, cut-off value of 11.53109/L, respec-
tively, While the areas under ROC curves of combination WBC and MPV/PC ratio was
0.674 (95%CI: 0.603 to 0.745) with a sensitivity of 39.8%, speciﬁcity of 88.1%. Kaplan-
Meier analysis and log-rank test revealed signiﬁcant survival differences between patients
with a MPV/PC ratio<7.55197102fL/ (109/L) and a MPV/PC ratio7.55197102fL/
(109/L) (P<0.001) and with a WBC <11.53109/L and a WBC 11.53109/L
(P<0.001). Subgroup analysis showed MPV/PC ratio had prognostic value for mortality
in patients with type A (P<0.001), surgery (P¼ 0.007) and only medication treatment
(P<0.001), no predictive value were found in patients with type B (P¼0.410) and
endovascular treatment (P¼ 0.822) patients, while prognostic value ofWBC formortality
was found in patients with type A (P¼0.004) and only medication treatment (P¼0.004).
Conclusions: the elevated MPV/PC ratio and WBC were important risk factors and
independently associated with mortality of patients with acute AD. These patients may
beneﬁt more from surgical intervention and endovascular treatment.
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Objectives: Patients with diabetes exhibit an increased risk of heart failure. Berberine
is a major isoquinoline alkaloid, which is the most abundant constituent of Chinese
herb Rhizoma coptidis, exerts anti-inﬂammatory effects in various disease models and
prevents diarrheic and inﬂammation in humans. Berberine may exert cardioprotective
effect against myocardial injury and dysfunction in diabetes. In this study, we
investigated the effects of berberine on myocardial dysfunction, ﬁbrosis, and
inﬂammation using a rat model of diabetic cardiomyopathy and primary neonatal rat
cardioﬁbroblasts exposed to high glucose and TGF-b.
Methods: Rats were randomized to receiving saline or berberine treatment (200
mg$kg-1$d-1, gavage) for 4 wks. Left ventricular function was measured by echo-
cardiography. Fibrosis and inﬂammation markers were evaluated by molecular
biology/biochemical techniques.
Results: Diabetic cardiomyopathy was characterized by declined LV ejection frac-
tions and decreased LV volumes associated with increased MAPK (JNK and P-38)
activation, enhanced expression of adhesion molecules ICAM-1, TNF-a, markers of
ﬁbrosis (TGF-b, CTGF, ﬁbronectin, collagen expression, MMP-2 and MMP-9), and
diminished AMPK, Akt and ERK phosphorylation. Remarkably, berberine attenuated
myocardial dysfunction (91.292.93% vs. 76.251.66% in diabetic rats, n¼4,
P<0.01), cardiac ﬁbrosis (TGF-b mRNA, 48.885.69% vs. 21514.65% in diabetic
rats, n¼3, P<0.05), inﬂammation and interrelated signaling pathways respectively.
Furthermore, berberine also attenuated the TGF-b-induced increased cardiac ﬁbrosis
and inﬂammation signaling pathways in cultured ﬁbroblasts, which berberine effects
were blocked by AMPK inhibition.
Conclusions: These results suggested that berberine may have great therapeutic po-
tential in the treatment of diabetic complications, and perhaps other cardiovascular
disorders, by attenuating ﬁbrosis and inﬂammation.
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Objectives: Glutathione peroxidase-1 (GPx1) is a pivotal intracellular antioxidant
enzyme that enzymatically reduces hydrogen peroxide to water to limit its harmful
effects. Recent ﬁndings indicate that the lack of GPx1 contributes to the risk of
atherosclerosis and cardiovascular disease. This study aims to identify a microRNA
(miRNA) targeting GPx1 to maintain redox homeostasis.
Methods: The cultured H9c2 cells were treated with different concentrationof H2O2 for
2h.Then, CCK8 assay was used to determine cell viability and the extent of apoptosis
was detected by TUNEL assays. Exogenous H2O2 induced endogenous Gpx1 expres-
sion change in H9c2 cells was assesed byWestern blot. Dual luciferase assay combined
with mutation and immunoblotting was used to validate the bioinformatically predicted
miRNAs. H9c2 cells were transfected with miR-181a mimics or miR-181a inhibitor,
H2O2 (400 uM) was added for the last 2 h. H9c2 cells were divided into the following 6
groups. The changes of apoptosis in H9c2 cells were quantitatively assayed with
Annexin V and PI double staining by Flow cytometric. LDH and MDA were simulta-
neously measured. The changes in intracellular ROS was detected by DCFH-DA
staining. The measurement of mitochondrial membrane Potential was detected by using
JC-1 probe.The expression of Bcl-2, Bax, cleaved caspase-3 in H9c2 cells were detected
by Western blotting. Immunoﬂuorescent detection of intracellular cytochrome c local-
ization was used by ﬂuorescent microscopy.
Results: 400uM H2O2 damage the antioxidant enzymes system resulting in Gpx1
expression decreased (P<0.05). The intersection of three algorithms identiﬁed four
potential miRNAs candidates: miR-7a, 125a, 181a and 423. At the apoptotic concen-
tration of H2O2, only miR-181a expressions were increased compared with normal
group, whereas other’s expressions decreased (P<0.05). A signiﬁcant decrease in
relative luciferase activity was observed when pmiR-RB-Gpx1-3’-UTR was co-trans-
fected with miR-181a mimics as compared with the scrambled miRNAs, and the miR-
181a mimics-mediated suppression was abolished by the mutation of the 3’-UTR miR-
181a binding site. Comparedwith anti-CTL group, the release of LDH and the content of
MDA, the production of ROS, the apoptosis rates, Bax, cleaved caspase-3 expression
and the release of cytochrome c from the mitochondrial intermembrane space into the
cytoplasm were signiﬁcantly decreased in anti-miR-181a group (P<0.05) and the
expression of Bcl-2 and mitochondrial membrane potential was correspond increased in
anti-miR-181a group while upregulation of miR-181a exacerbated it (P<0.05).
Conclusions: we have demonstrated that the expression of miR-181a is up-regulated
in H2O2-treated H9c2 cells and that miR-181a inhibitor confers cardiac protection
against oxidative stress-induced H9c2 cells apoptosis through directly inhibiting the
Gpx1 expression and the ROS generation which maintains mitochondria membrane
integrity and inhibits the activation of mitochondrial apoptotic pathway under
oxidative stress conditions. These novel ﬁndings may have extensive implications for
the diagnosis and therapy of a variety of cardiovascular diseases related to ROS such
as atherosclerosis, hypertension, restenosis after angioplasty or bypass, diabetic
vascular complications, and transplantation arteriopathy.
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and nerve stimulation reduces its activity and antagonizes the arrhythmias. The rapid
delayed rectiﬁer potassium channel (IKr) is involved in repolarization of cardiac ac-
tion potential. We investigated the effects of HMME-induced SDT on the biophysical
properties of IKr channel and the underlying structrue-activity relationships.
Methods: The effects of HMME-SDT were examined on the IKr channels in the
stable transfected HEK293 cells using a whole-cell patch clamp technique, western
blot analysis and immunoﬂuorescence experiment. The pharmacokinetics and tissue
distribution determination of HMME in rats were determined by a validated RP-HPLC
method.
Results: HMME-SDT induced decrease of current amplitude in time-dependent.
HMME-SDT reduced IKr tail current from 69.55.3 pA/pF in control group to
55.63.1 pA/pF in the 1 min group, 52.81.9 pA/pF (3 min) and 16.70.8 pA/pF (5
min); the corresponding current densities of HMME-SDT-treated cells were 39.82.9
pA/pF, 31.23.0 pA/pF and 15.90.7 pA/pF, respectively. HMME had binding af-
ﬁnity for the open and inactivated state of IKr channel. HMME distributed quickly in
rats, which was found to be in high concentration. HMME-SDT had no effect on the
generation and expression of IKr channels.
Conclusions: In conclusion, HMME-SDT is a potent way to block IKr channels, and
may be a potential treatment as an antiarrhythmic method.
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Objectives: Study was designed to determine the changes of voltage-gated K+ cur-
rents (Ikv) in the mesenteric arterial smooth muscle cells of rat during the gradual
apoptosis process by arsenic trioxide treatment.
Methods: Effect of arsenic trioxide on vascular smooth muscle cells was determined
by MTT assay. Apoptosis was evaluated by TUNEL method and voltage-gated K+
currents were recorded by whole-cell patch-clamp.
Results: Arsenic trioxide reduced vascular smooth muscle cell viability in a con-
centration-dependent manner after 48h exposure of the cells to 2-32 mmol/l arsenic
trioxide. Arsenic trioxide 8mmol/l (48h) induced apoptosis in the cultured mesenteric
arterial smooth muscle cells. Apoptosis ratio in arsenic trioxide 8 mmol/l (48h) in-
cubation group was 211.3% vs. 0.90.2% in control group (n¼5, P<0.05). This
concentration was used to treat the primary cultured mesenteric arterial smooth muscle
cells for 48h and the voltage-gated K+ currents currents densities (Ikv) was down-
regulated. The densities of the Ikv in 8 mmol/l arsenic trioxide groups were 4.180.85
pA/pF vs. 16.861.22 pA/pF in the control group at +60mv (n¼6, P<0.05).
Conclusions: Chronic As2O3 treatment induced vascular toxicity is mediated, at least
in part, by apoptosis of cultured mesenteric arterial SMCs. The densities of Ikv in
cultured mesenteric arterial smooth muscle cells down-regulated during the gradual
apoptotic process maybe a self-protective mechanism to reduce the loss by apoptotic
stimuli, and also accelerate vascular disease.
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Objectives: Arrhythmogenic right ventricular dysplasia (ARVD) is a genetically
determined disorder, characterized by two components, cardiomyopathy and
arrhythmia. To date, the ion channel-related pathogenesis underlying this phenomenon
has been poorly understood. The aim of this study was to systematically evaluate the
sodium channel variants in Chinese patients with ARVD.
Methods: Patients meeting the diagnostic guidelines of ARVD revised in 2010 were
enrolled. All exons and exon-intron boundaries of the SCN5A gene and desmosomal
genes known to be associated with ARVD, including DSC2, DSG2, DSP, JUP, and
PKP2 were sequenced by direct DNA sequencing.
Results: A total of 12 unrelated index patients were included. The eight of them
developed ventricular tachycardia (VT) and ventricular ﬁbrillation (VF), one of them
showed Epsilon wave, one of them showed type 1 Brugada wave, seven of them
exhibited syncope or dizziness, and none of the patients had a family history of SCD.
A new missense heterozygote mutation, I137M, in SCN5A was found in proband 5
with recurrent palpitations and a high incidence of VT. I137M is in exon 4 of SCN5A,
at the S1 segment in domain I of Nav1.5, and predicted a substitution of isoleucine for
methionine at codon site 137 (P. Ile137Met, I137M). I137M was not detected in 400
healthy control chromosomes from individuals of the same ethnic background, which
indicated that this mutation was a conservative site in the SCN5A gene, and the
encoded protein Nav1.5 might have a functional defect resulting in arrhythmia.
Conclusions: This study for the ﬁrst time systematically evaluated the sodium channel
variants in Chinese patients with ARVD, and found a new SCN5A mutation, I137M.
The result increases insight to the genetic pathogenesis of ARVD in Chinese patients,
and SCN5A genetic screening should be done in patients with ARVD and VT/VF.asic and Translational Medicine C65
